docking software (AUTODOCK GmbH)
90
Structured Review
AUTODOCK GmbH
docking software
Docking Software, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+docking+simulations+fred+program/docking+software/us11214804-514-9-16
Average 90 stars, based on 1 article reviews
Docking Software, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+docking+simulations+fred+program/docking+software/us11214804-514-9-16
Average 90 stars, based on 1 article reviews
docking software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Anti-Anxiety Effects of Essential Oil Microemulsion in Chronic Unpredictable Mild Stress-Induced Rats: Preparation, Characterization, and Mechanisms Article Snippet: Protein structures were downloaded from PDB ( https://www.rcsb.org/ ), prepared using PyMOL, and docked with Article Title: Investigating the Effects of Chelidonic Acid on Oxidative Stress-Induced Premature Cellular Senescence in Human Skin Fibroblast Cells Article Snippet: All docking results were performed with Article Title: Mechanism of Ligusticum wallichii-Borneol in the Treatment of Cerebral Ischemic Stroke in Rats Based On Network Pharmacology, Molecular Docking, and Experimental Verification. Article Snippet: Proteins were prepared for Article Title: Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells. Article Snippet: The possible binding sites and docked conformations were obtained when the ligand poses with the lowest docking energy using Article Title: Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes. Article Snippet: THE unique therapeutic activity of methionine aminopeptidases (MetAPs) has been exploited for the development of new drug motifs over the past three decades (Burkey et al., 2018; Cheruvallath et al., 2016; Grocin et al., 2021; Heinrich et al., 2017; Ingber et al., 1990; Kusaka et al., 1991; McBride et al., 2016).. MetAP is a dinuclear metalloprotease that removes an Nterminal methionine residue from nascent proteins and facilitates posttranslational modifications that are essential for the translocation, activation, regulation, and degradation of proteins in eukaryotic cells (Han & Weiss, 2018; Helgren et al., 2016).. MetAP has emerged as an influential drug target, leading to the synthesis of new compounds containing different functional groups for active drug design. Article Title: PPARG/SPP1/CD44 signaling pathway in alveolar macrophages: Mechanisms of lipid dysregulation and therapeutic targets in idiopathic pulmonary fibrosis Article Snippet: Afterwards, the compounds were docked 50 times using Binding Assay:Article Title: Exploring a New Ruthenium(II) Complex with High DNA Binding Ability as a Novel Efficient Luminescent Intercalation Agent to Construct a Label-Free ECL/PL Dual-Mode Biosensor. Article Snippet: Get e-Alerts ARTICLE | February 25, 2025 Exploring a New Ruthenium(II) Complex with High DNA Binding Ability as a Novel E cient Luminescent Intercalation Agent to Construct a Label-Free ECL/PL Dual-Mode Biosensor , , , , and Analytical Chemistry Cite this: Anal.. Chem.. 2025, 97, 9, 5297–5305 https://doi.org/10.1021/acs.analchem.5c00173 Copyright © 2025 American Chemical Society Request reuse permissions Cite Share Jump to Yaoyao Xu Rongxiu Deng Junli Jia Weiqiang Guo Yuyang Zhou* Open PDF Supporting Information (1) Article Views 611 Altmetric Citations Learn about these metrics Published February 25, 2025 5/28/25, 11:02 PM Exploring a New Ruthenium(II) Complex with High DNA Binding Ability as a Novel Efficient Luminescent Intercalation Agent to Const... https://pubs.acs.org/doi/10.1021/acs.analchem.5c00173 2/24 Ruthenium(II) complexes with special ligands have been widely recognized in numerous elds and attributed to their outstanding DNA binding capacity. Software:Article Title: Exploring a New Ruthenium(II) Complex with High DNA Binding Ability as a Novel Efficient Luminescent Intercalation Agent to Construct a Label-Free ECL/PL Dual-Mode Biosensor. Article Snippet: Get e-Alerts ARTICLE | February 25, 2025 Exploring a New Ruthenium(II) Complex with High DNA Binding Ability as a Novel E cient Luminescent Intercalation Agent to Construct a Label-Free ECL/PL Dual-Mode Biosensor , , , , and Analytical Chemistry Cite this: Anal.. Chem.. 2025, 97, 9, 5297–5305 https://doi.org/10.1021/acs.analchem.5c00173 Copyright © 2025 American Chemical Society Request reuse permissions Cite Share Jump to Yaoyao Xu Rongxiu Deng Junli Jia Weiqiang Guo Yuyang Zhou* Open PDF Supporting Information (1) Article Views 611 Altmetric Citations Learn about these metrics Published February 25, 2025 5/28/25, 11:02 PM Exploring a New Ruthenium(II) Complex with High DNA Binding Ability as a Novel Efficient Luminescent Intercalation Agent to Const... https://pubs.acs.org/doi/10.1021/acs.analchem.5c00173 2/24 Ruthenium(II) complexes with special ligands have been widely recognized in numerous elds and attributed to their outstanding DNA binding capacity. Article Title: PharmacoNet: deep learning-guided pharmacophore modeling for ultra-large-scale virtual screening Article Snippet: .. Compared to AutoDock Vina, the fastest |